Arcutis Biotherapeutics, Inc. Common Stock
Symbol: ARQT (NASDAQ)
14.39
▼ (-1.33%) -0.194
Company Description:
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Key Stats
- Today's Open: $14.268
- Today's High: $14.52
- Today's Low: $14.141
- Today's Volume: 826.28K
- Yesterday Close: $14.58
- Yesterday High: $14.6583
- Yesterday Low: $14.31
- Yesterday Volume: 1.17M
- Last Min Volume: 0
- Last Min High: $14.427
- Last Min Low: $14.386
- Last Min VWAP: $0
Company Profile
- Name: Arcutis Biotherapeutics, Inc. Common Stock
- Website: https://www.arcutis.com
- Listed Date: 2020-01-31
- Location: WESTLAKE VILLAGE, CA
- Market Status: Active
- CIK Number: 0001787306
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.74B
- Round Lot: 100
- Outstanding Shares: 119.20M
- Asset Type: CS
RECENT FILINGS FOR ARQT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-01 | 144 | View |
| 2025-07-14 | 4 | View |
| 2025-07-14 | 144 | View |
| 2025-07-10 | 144 | View |
| 2025-07-02 | 4 | View |
| 2025-07-01 | 144 | View |
| 2025-06-20 | 4 | View |
| 2025-06-18 | 144 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-06 | 4 | View |
Latest News on ARQT